Latest News

Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

Bridging the gap in Phase 1 clinical studies

April 2023

Here at Richmond Pharmacology, we focus mainly on Japanese cohorts in order to fast track global marketing authorisations in these important markets, ultimately reaching patients sooner.

View Article

Futureproofing early phase clinical research for the next generation of investigators.

March 2023

Richmond Pharmacology’s experienced Principal investigators and Co-investigators recently gave expert feedback on the ICH M11 (CeSHarP) protocol template.

View Article

How Does Social Time Contribute to a Positive Workplace Culture?

March 2023

Read the blog by Richmond Pharmacology’s Chair of the Social Committee and Head of Marketing, Elizabeth Romano about how being social improves organisational culture and embeds the core values.

View Article

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

January 2023

Keith Berelowitz will be responsible for ensuring that all ethical possibilities are explored in relation to new research.

View Article

Unlocking the potential of data sharing

January 2023

Dilshat Djumonov explores how GDPR is central to protecting private information while presenting unique challenges to the pharmaceutical clinical trials industry.

View Article

How telemonitoring can revolutionise the way we treat patients – Tom York

November 2022

Richmond Pharmacology always searches for the most innovative processes to improve clinical trials and the patients’ experiences and treatments.

View Article

Meet the experts

Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.

Careers at Richmond

We are on the lookout for people who love what they do, strive for excellence and who want to make a difference.

Our Videos

Learn more about Richmond Pharmacology by viewing some of our videos.

Richmond supports Beam Therapeutics to make significant step forward in potential one-time gene editing treatment for Alpha-1

March 30, 2026

Beam Therapeutics has announced compelling updated clinical data from its ongoing Phase 1/2 Trial of BEAM-302 as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD).

Clinical Trials Innovation Programme

10 - 11 February 2026

Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.

View event

Low data variability

Exceptional ECG generation

Experts in cardiac safety

Our specialist services

サービス一覧

News

Stay up to date with the latest activity at Richmond Pharmacology

Bridging the gap in Phase 1 clinical studies

Futureproofing early phase clinical research for the next generation of investigators.

How Does Social Time Contribute to a Positive Workplace Culture?

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

Unlocking the potential of data sharing

How telemonitoring can revolutionise the way we treat patients – Tom York

Meet the experts

Careers at Richmond

Our Videos

Latest news

Richmond supports Beam Therapeutics to make significant step forward in potential one-time gene editing treatment for Alpha-1

Events

Clinical Trials Innovation Programme

About us

Knowledge Base

Connect with us